Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Rejnmark

Showing results (61-70 of 264) with videos related to

Pageof 27
Sort By:
Calcified Tissue International|January 26, 2008
Selective serotonin reuptake inhibitors and other antidepressants and risk of fracturePeter Vestergaard, Lars Rejnmark, Leif Mosekilde
The Journal of Clinical Endocrinology and Metabolism|March 13, 2019
Effect of Parathyroidectomy on Cardiovascular Risk Factors in Primary Hyperparathyroidism: A Randomized Clinical TrialHenriette Ejlsmark-Svensson, Lars Rolighed, Lars Rejnmark
Ugeskrift for Laeger|September 15, 2005
[Strontium ranelate: a new therapeutic principle for postmenopausal osteoporosis]Leif Mosekilde, Lars Rejnmark Nielsen, Peter Vestergaard
Ugeskrift for Laeger|April 5, 2005
[Drugs with side effects affecting calcium homeostasis, bone metabolism and risk of fractures]Lars Rejnmark Nielsen, Peter Vestergaard, Leif Mosekilde
Clinical Endocrinology|April 12, 2019
T-score differences and nonprogression in lumbar vertebrae as predictors of vertebral fracturesSiv E Lajlev, Lars Rejnmark, Torben Harsløf
Ugeskrift for Laeger|September 7, 2004
[Teriparatide (human recombinant 1-34 parathyroid hormone)--a new treatment regimen for severe osteoporosis]Peter Vestergaard, Lars Rejnmark Nielsen, Leif Mosekilde
European Journal of Endocrinology|August 25, 2011
Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controlsAnne Kristine Amstrup, Lars Rejnmark, Leif Mosekilde
Ugeskrift for Laeger|January 6, 2006
[Cinacalcet--a new drug for the treatment of secondary hyperparathyroidism in patients with uraemia, parathyroid cancer or primary hyperparathyroidism]Peter Vestergaard, Lars Rejnmark Nielsen, Leif Mosekilde
Calcified Tissue International|August 4, 2014
Effects on calcium homeostasis of changing PTH replacement therapy of postoperative hypoparathyroidism from intact PTH to teriparatide: a case seriesLise Sofie Bislev, Tanja Sikjaer, Lars Rejnmark
Ugeskrift for Laeger|April 5, 2005
[Physical activity, smoking and the significance of vitamins A and D in osteoporosis]Pia A Eiken, Peter Schwarz, Lars Rejnmark Nielsen
Pageof 27

Showing results (61-70 of 264) with videos related to

Sort By:
Pageof 27
Calcified Tissue International|January 26, 2008
Selective serotonin reuptake inhibitors and other antidepressants and risk of fracturePeter Vestergaard, Lars Rejnmark, Leif Mosekilde
The Journal of Clinical Endocrinology and Metabolism|March 13, 2019
Effect of Parathyroidectomy on Cardiovascular Risk Factors in Primary Hyperparathyroidism: A Randomized Clinical TrialHenriette Ejlsmark-Svensson, Lars Rolighed, Lars Rejnmark
Ugeskrift for Laeger|September 15, 2005
[Strontium ranelate: a new therapeutic principle for postmenopausal osteoporosis]Leif Mosekilde, Lars Rejnmark Nielsen, Peter Vestergaard
Ugeskrift for Laeger|April 5, 2005
[Drugs with side effects affecting calcium homeostasis, bone metabolism and risk of fractures]Lars Rejnmark Nielsen, Peter Vestergaard, Leif Mosekilde
Clinical Endocrinology|April 12, 2019
T-score differences and nonprogression in lumbar vertebrae as predictors of vertebral fracturesSiv E Lajlev, Lars Rejnmark, Torben Harsløf
Ugeskrift for Laeger|September 7, 2004
[Teriparatide (human recombinant 1-34 parathyroid hormone)--a new treatment regimen for severe osteoporosis]Peter Vestergaard, Lars Rejnmark Nielsen, Leif Mosekilde
European Journal of Endocrinology|August 25, 2011
Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controlsAnne Kristine Amstrup, Lars Rejnmark, Leif Mosekilde
Ugeskrift for Laeger|January 6, 2006
[Cinacalcet--a new drug for the treatment of secondary hyperparathyroidism in patients with uraemia, parathyroid cancer or primary hyperparathyroidism]Peter Vestergaard, Lars Rejnmark Nielsen, Leif Mosekilde
Calcified Tissue International|August 4, 2014
Effects on calcium homeostasis of changing PTH replacement therapy of postoperative hypoparathyroidism from intact PTH to teriparatide: a case seriesLise Sofie Bislev, Tanja Sikjaer, Lars Rejnmark
Ugeskrift for Laeger|April 5, 2005
[Physical activity, smoking and the significance of vitamins A and D in osteoporosis]Pia A Eiken, Peter Schwarz, Lars Rejnmark Nielsen
Pageof 27